Literature DB >> 16704554

Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.

S Boonen1, D Vanderschueren, P Haentjens, P Lips.   

Abstract

Combined calcium and vitamin D supplementation is an essential component of the management of osteoporosis, supported by a strong scientific rationale. The types of individuals who should receive calcium and vitamin D supplements are those: (i) patients with documented osteoporosis receiving antiresorptive or anabolic treatment; (ii) patients receiving glucocorticoids; and (iii) individuals with or at high risk of calcium and/or vitamin D insufficiencies, in particular older women and men. This article describes the evidence base that supports targeting these groups. Benefits are most apparent when 800 IU day(-1) vitamin D is complemented with a dose of 1000-1200 mg day(-1) elemental calcium. Compliance is also key to optimizing clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704554     DOI: 10.1111/j.1365-2796.2006.01655.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  39 in total

1.  Development of a tool for the assessment of calcium and vitamin D intakes in clinical settings.

Authors:  M Severo; C Lopes; R Lucas; H Barros
Journal:  Osteoporos Int       Date:  2008-06-05       Impact factor: 4.507

2.  Nutrition and aging. The Carla Workshop.

Authors:  G Abellan van Kan; G Gambassi; L C P G M de Groot; S Andrieu; T Cederholm; E André; J P Caubère; J P Bonjour; P Ritz; A Salva; A Sinclair; B Vellas; J Daydé; J Deregnaucourt; C Latgé
Journal:  J Nutr Health Aging       Date:  2008 Jun-Jul       Impact factor: 4.075

3.  Persistence with calcium and vitamin D in elderly patients after hip fracture.

Authors:  Andrea Giusti; Antonella Barone; Monica Razzano; Mauro Oliveri; Monica Pizzonia; Ernesto Palummeri; Giulio Pioli
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

4.  Treatment of glucocorticoid-induced osteoporsis.

Authors:  Gherardo Mazziotti; Andrea Giustina; Ernesto Canalis; John P Bilezikian
Journal:  Ther Adv Musculoskelet Dis       Date:  2009-02       Impact factor: 5.346

5.  Corticosteroid use in neuro-oncology: an update.

Authors:  Patrick Roth; Caroline Happold; Michael Weller
Journal:  Neurooncol Pract       Date:  2014-10-09

6.  Effects of medication assessment as part of a comprehensive geriatric assessment on drug use over a 1-year period: a population-based intervention study.

Authors:  Pasi Lampela; Sirpa Hartikainen; Piia Lavikainen; Raimo Sulkava; Risto Huupponen
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

Review 7.  Vitamin D supplements with or without calcium to prevent fractures.

Authors:  Paul Lips; Evelien Gielen; Natasja M van Schoor
Journal:  Bonekey Rep       Date:  2014-03-05

8.  An Asian viewpoint on the use of vitamin D and calcium in osteoporosis treatment: physician and patient attitudes and beliefs.

Authors:  Siew Pheng Chan; Boyd B Scott; Shuvayu S Sen
Journal:  BMC Musculoskelet Disord       Date:  2010-10-26       Impact factor: 2.362

9.  Value of a new fixed-combination pack of bisphosphonate, calcium and vitamin D in the therapy of osteoporosis: results of two quantitative patient research studies.

Authors:  Johann D Ringe; Patrice Fardellone; Hans-Peter Kruse; Michael Amling; Stefan A P van der Geest; Gerd Möller
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 10.  Progress in osteoporosis and fracture prevention: focus on postmenopausal women.

Authors:  Kenneth G Saag; Piet Geusens
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.